Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
43.6 USD +2.44% Intraday chart for Apellis Pharmaceuticals, Inc. +4.01% -27.16%
May. 14 Transcript : Apellis Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
May. 14 Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility With Sixth Street MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $3,743,605, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $1,068,161, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $564,050, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $645,838, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $4,297,549, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals, Inc. Announces Appointment of Philip Ferrone, M.D as Chief Medical Retina Advisor, Effective March 18, 2024
CI
Apellis Pharmaceuticals Insider Sold Shares Worth $16,028,706, According to a Recent SEC Filing
MT
EyePoint Pharmaceuticals Names Ramiro Ribeiro Chief Medical Officer
MT
ZYUS Life Sciences Appoints Dr. Hance Clarke to Clinical Advisory Committee
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $272,975, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $271,943, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $254,329, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Names Adam Townsend as Chief Operating Officer
MT
Apellis Pharmaceuticals, Inc. Appoints Adam Townsend as Chief Operating Officer
CI
Apellis Pharmaceuticals Insider Sold Shares Worth $283,268, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $524,514, According to a Recent SEC Filing
MT
Apellis Pharmaceuticals Insider Sold Shares Worth $1,467,240, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLS Stock
  4. News Apellis Pharmaceuticals, Inc.
  5. Insiders